| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $846.3M | $817.1M | $752.5M |
| YoY Revenue Growth % | +3.6% | +8.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $341.8M | $340.9M | $315.0M |
| Operating Margin % | 40.4% | 41.7% | 41.9% |
| Net Income (GAAP) | $246.9M | $274.2M | $258.1M |
| EBITDA (Normalized) | $348.4M | $348.8M | $342.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $382.1M | $385.2M | $333.8M |
| Capital Expenditures (CapEx) | $8.2M | $9.9M | $33.9M |
| Free Cash Flow (FCF) | $373.9M | $375.3M | $299.9M |
| FCF Margin % | 44.2% | 45.9% | 39.9% |
| Return on Invested Capital (ROIC %) | 27.7% | 26.3% | 12.9% |
| Cash & Short-Term Equivalents | $519.7M | $544.5M | — |
| Total Debt (Short + Long Term) | $349.5M | $180.3M | $747.0M |
| Total Stockholders' Equity | $1.15B | $1.39B | $1.53B |